Compound ID | 1633
Class: Beta-lactamase inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Activity demonstrated against E.coli expressing NDM-1 |
Institute where first reported: | Northwest University, Xi'an, China |
Year first mentioned: | 2019 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://www.nature.com/articles/s41429-018-0121-4 |